Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Niemann-Pick Disease, Type C D052556 1 associated lipids
Farber Lipogranulomatosis D055577 1 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Sensation Disorders D012678 2 associated lipids
Ileus D045823 3 associated lipids
Fabry Disease D000795 4 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Ovarian Diseases D010049 5 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Pregnancy, Ectopic D011271 5 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Teratocarcinoma D018243 7 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Eye Abnormalities D005124 7 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Cardiomyopathies D009202 10 associated lipids
Retinal Detachment D012163 10 associated lipids
Influenza, Human D007251 11 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Lung Injury D055370 14 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Thrombocytopenia D013921 15 associated lipids
Vascular Diseases D014652 16 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Tuberculosis D014376 20 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Sarcoma 180 D012510 21 associated lipids
Anemia D000740 21 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Hypersensitivity D006967 22 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Pulmonary Edema D011654 23 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Fibrosis D005355 23 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Endotoxemia D019446 27 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Knapp M Cardioprotective role of sphingosine-1-phosphate. 2011 J. Physiol. Pharmacol. pmid:22314562
Berdyshev EV et al. Intracellular S1P generation is essential for S1P-induced motility of human lung endothelial cells: role of sphingosine kinase 1 and S1P lyase. 2011 PLoS ONE pmid:21304987
Schuchardt M et al. Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system. 2011 Br. J. Pharmacol. pmid:21309759
Kikuta J et al. [Encounter of cancer cells with bone. In vivo imaging of osteoclasts and their precursors in intact bone tissues]. 2011 Clin Calcium pmid:21358058
Mair N et al. Genetic evidence for involvement of neuronally expressed S1P₁ receptor in nociceptor sensitization and inflammatory pain. 2011 PLoS ONE pmid:21359147
Morris MA et al. Prevention, but not cure, of autoimmune diabetes in a NOD.scid transfer model by FTY720 despite effective modulation of blood T cells. 2011 Autoimmunity pmid:20695767
Ishii T et al. The role of sphingosine 1-phosphate in migration of osteoclast precursors; an application of intravital two-photon microscopy. 2011 Mol. Cells pmid:21360199
Antel J and Hohlfeld R Modulation of sphingosine 1-phosphate signaling in neurologic disease. 2011 Neurology pmid:21360856
Lépine S et al. Sphingosine-1-phosphate phosphohydrolase-1 regulates ER stress-induced autophagy. 2011 Cell Death Differ. pmid:20798685
Kim MG et al. CD4+ CD25+ regulatory T cells partially mediate the beneficial effects of FTY720, a sphingosine-1-phosphate analogue, during ischaemia/reperfusion-induced acute kidney injury. 2011 Nephrol. Dial. Transplant. pmid:20702533
Jiang Z et al. Metabonomic study on women of reproductive age treated with nutritional intervention: screening potential biomarkers related to neural tube defects occurrence. 2011 Biomed. Chromatogr. pmid:20812204
Siow D and Wattenberg B The compartmentalization and translocation of the sphingosine kinases: mechanisms and functions in cell signaling and sphingolipid metabolism. 2011 Crit. Rev. Biochem. Mol. Biol. pmid:21864225
Adyshev DM et al. Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement. 2011 Cell. Signal. pmid:21864676
Selim S et al. Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions. 2011 Clin. Sci. pmid:21749329
Kim DS et al. Sphingosine-1-phosphate decreases melanin synthesis via microphthalmia-associated transcription factor phosphorylation through the S1P3 receptor subtype. 2011 J. Pharm. Pharmacol. pmid:21749389
Kojima K and Inouye K Activation of matriptase zymogen. 2011 J. Biochem. pmid:21737400
AL-Shawaf E et al. GVI phospholipase A2 role in the stimulatory effect of sphingosine-1-phosphate on TRPC5 cationic channels. 2011 Cell Calcium pmid:21742378
Bautista-Pérez R et al. Sphingosine-1-phosphate induced vasoconstriction is increased in the isolated perfused kidneys of diabetic rats. 2011 Diabetes Res. Clin. Pract. pmid:21775010
Roviezzo F et al. Sphingosine-1-phosphate modulates vascular permeability and cell recruitment in acute inflammation in vivo. 2011 J. Pharmacol. Exp. Ther. pmid:21421740
Murakami M et al. Sphingosine kinase 1/S1P pathway involvement in the GDNF-induced GAP43 transcription. 2011 J. Cell. Biochem. pmid:21769916
Yu Y and Qin SC [An active lipid signaling molecule: sphingosine-1-phosphate and its biological characteristics]. 2011 Sheng Li Ke Xue Jin Zhan pmid:21770269
Tanfin Z et al. ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium. 2011 Cell. Signal. pmid:21803151
Gault CR and Obeid LM Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy. 2011 Crit. Rev. Biochem. Mol. Biol. pmid:21787121
Lee YS et al. Serine palmitoyltransferase inhibitor myriocin induces growth inhibition of B16F10 melanoma cells through G(2) /M phase arrest. 2011 Cell Prolif. pmid:21645154
Zhao Z et al. Sphingosine-1-phosphate promotes the differentiation of human umbilical cord mesenchymal stem cells into cardiomyocytes under the designated culturing conditions. 2011 J. Biomed. Sci. pmid:21645412
Kim ES et al. Sphingosine 1-phosphate regulates matrix metalloproteinase-9 expression and breast cell invasion through S1P3-Gαq coupling. 2011 J. Cell. Sci. pmid:21652634
Lim KG et al. (R)-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: Effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cells. 2011 Cell. Signal. pmid:21620961
Egom EE et al. Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury. 2011 Am. J. Physiol. Heart Circ. Physiol. pmid:21705677
Yangyuoru PM et al. Determination of sphingosine kinase 2 activity using fluorescent sphingosine by capillary electrophoresis. 2011 Electrophoresis pmid:21706498
Kawahara A [Genetic dissection of cardiac morphogenesis in zebrafish]. 2011 Seikagaku pmid:21706872
Burns TA and Luberto C Sphingolipid metabolism and leukemia: a potential for novel therapeutic approaches. 2011 Anticancer Agents Med Chem pmid:21707485
Cuvillier O and Ader I Hypoxia-inducible factors and sphingosine 1-phosphate signaling. 2011 Anticancer Agents Med Chem pmid:21707486
Bedia C et al. Regulation of autophagy by sphingolipids. 2011 Anticancer Agents Med Chem pmid:21707487
Weigert A et al. S1P regulation of macrophage functions in the context of cancer. 2011 Anticancer Agents Med Chem pmid:21707489
Watters RJ et al. Targeting sphingosine-1-phosphate receptors in cancer. 2011 Anticancer Agents Med Chem pmid:21707490
Sánchez BA et al. Targeted analysis of sphingoid precursors in human biofluids by solid-phase extraction with in situ derivatization prior to μ-LC-LIF determination. 2011 Anal Bioanal Chem pmid:21394454
Dickson MA et al. A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors. 2011 Clin. Cancer Res. pmid:21257722
Kanno T and Nishizaki T Endogenous sphingosine 1-phosphate regulates spontaneous glutamate release from mossy fiber terminals via S1P(3) receptors. 2011 Life Sci. pmid:21683714
Kumar A et al. S1P lyase regulates DNA damage responses through a novel sphingolipid feedback mechanism. 2011 Cell Death Dis pmid:21368890
Schröder M et al. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen. 2011 Mol. Immunol. pmid:21435724
Kujjo LL et al. Chemotherapy-induced late transgenerational effects in mice. 2011 PLoS ONE pmid:21437292
Bandhuvula P et al. S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart. 2011 Am. J. Physiol. Heart Circ. Physiol. pmid:21335477
Kennedy AJ et al. Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells. 2011 J. Med. Chem. pmid:21495716
Jenkins RW et al. Regulation of CC ligand 5/RANTES by acid sphingomyelinase and acid ceramidase. 2011 J. Biol. Chem. pmid:21335555
Pinschewer DD et al. Impact of sphingosine 1-phosphate modulation on immune outcomes. 2011 Neurology pmid:21339486
Mehling M et al. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis. 2011 Neurology pmid:21339487
Hla T and Brinkmann V Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation. 2011 Neurology pmid:21339489
Soliven B et al. The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators. 2011 Neurology pmid:21339490
Brecht K et al. Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2. 2011 FASEB J. pmid:21450910
Benamer N et al. Electrophysiological and functional effects of sphingosine-1-phosphate in mouse ventricular fibroblasts. 2011 Biochem. Biophys. Res. Commun. pmid:21420933
Ocaña-Morgner C et al. Sphingosine 1-phosphate-induced motility and endocytosis of dendritic cells is regulated by SWAP-70 through RhoA. 2011 J. Immunol. pmid:21421853
Delogu G et al. Lysophosphatidic acid enhances antimycobacterial response during in vivo primary Mycobacterium tuberculosis infection. 2011 Cell. Immunol. pmid:21703599
Strub GM et al. Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration. 2011 FASEB J. pmid:20959514
Sekine Y et al. HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion. 2011 Prostate pmid:20979115
Noguchi K and Chun J Roles for lysophospholipid S1P receptors in multiple sclerosis. 2011 Crit. Rev. Biochem. Mol. Biol. pmid:20979571
Becker S et al. Follicular fluid high-density lipoprotein-associated sphingosine 1-phosphate (S1P) promotes human granulosa lutein cell migration via S1P receptor type 3 and small G-protein RAC1. 2011 Biol. Reprod. pmid:20980685
Barra V et al. Apoptotic cell-derived factors induce arginase II expression in murine macrophages by activating ERK5/CREB. 2011 Cell. Mol. Life Sci. pmid:20949368
Greenspon J et al. Sphingosine-1-phosphate regulates the expression of adherens junction protein E-cadherin and enhances intestinal epithelial cell barrier function. 2011 Dig. Dis. Sci. pmid:20936358
Wu LY et al. Metabolite modulation of HeLa cell response to ENOX2 inhibitors EGCG and phenoxodiol. 2011 Biochim. Biophys. Acta pmid:21571040
Jeffery DR et al. Fingolimod for the treatment of relapsing multiple sclerosis. 2011 Expert Rev Neurother pmid:21158700
Chi H Sphingosine-1-phosphate and immune regulation: trafficking and beyond. 2011 Trends Pharmacol. Sci. pmid:21159389
Jee BC et al. Dose-dependent effect of sphingosine-1-phosphate in mouse oocyte maturation medium on subsequent embryo development. 2011 Gynecol. Obstet. Invest. pmid:21160167
Kim YM et al. G(alpha)12/13 induction of CYR61 in association with arteriosclerotic intimal hyperplasia: effect of sphingosine-1-phosphate. 2011 Arterioscler. Thromb. Vasc. Biol. pmid:21212405
Kharel Y et al. A rapid assay for assessment of sphingosine kinase inhibitors and substrates. 2011 Anal. Biochem. pmid:21216217
Gaveglio VL et al. Metabolic pathways for the degradation of phosphatidic acid in isolated nuclei from cerebellar cells. 2011 Arch. Biochem. Biophys. pmid:21216221
Ter Braak M et al. Cis-4-methylsphingosine is a sphingosine-1-phosphate receptor modulator. 2011 Biochem. Pharmacol. pmid:21163254
Markiewicz M et al. Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells. 2011 Microcirculation pmid:21166920
Sassoli C et al. Effects of S1P on skeletal muscle repair/regeneration during eccentric contraction. 2011 J. Cell. Mol. Med. pmid:21199328
Jang S et al. Modulation of sphingosine 1-phosphate and tyrosine hydroxylase in the stress-induced anxiety. 2011 Neurochem. Res. pmid:21076868
Jongsma M et al. LPA is a chemorepellent for B16 melanoma cells: action through the cAMP-elevating LPA5 receptor. 2011 PLoS ONE pmid:22195035
Finney CA et al. S1P is associated with protection in human and experimental cerebral malaria. 2011 Mol. Med. pmid:21556483
Bradley ME et al. The in vitro metabolism of sphingosine-1-phosphate: identification; inhibition and pharmacological implications. 2011 Eur. J. Pharmacol. pmid:21970805
Lan T et al. Sphingosine kinase-1 pathway mediates high glucose-induced fibronectin expression in glomerular mesangial cells. 2011 Mol. Endocrinol. pmid:21998146
Kang H et al. Fluid shear stress and sphingosine 1-phosphate activate calpain to promote membrane type 1 matrix metalloproteinase (MT1-MMP) membrane translocation and endothelial invasion into three-dimensional collagen matrices. 2011 J. Biol. Chem. pmid:22002053
Kartal M et al. Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells. 2011 Nutr Cancer pmid:21500096
Costello RW et al. Mechanism of sphingosine 1-phosphate- and lysophosphatidic acid-induced up-regulation of adhesion molecules and eosinophil chemoattractant in nerve cells. 2011 Int J Mol Sci pmid:21686182
Serebrov VIu et al. [Activity of the sphingomyelin cycle enzymes and concentration of products of sphingomyelin degradation in the rat liver in the course of acute toxic hepatitis]. 2010 Mar-Apr Biomed Khim pmid:21341516
Egom EE et al. Cardioprotection in ischemia/reperfusion injury: spotlight on sphingosine-1-phosphate and bradykinin signalling. 2010 Prog. Biophys. Mol. Biol. pmid:20080123
Dunlap KA et al. The sphingosine 1-phosphate (S1P) signaling pathway is regulated during pregnancy in sheep. 2010 Biol. Reprod. pmid:20107206
Takabe K et al. Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. 2010 J. Biol. Chem. pmid:20110355
Kilbey A et al. Runx regulation of sphingolipid metabolism and survival signaling. 2010 Cancer Res. pmid:20587518
Yonesu K et al. A novel sphingosine-1-phosphate receptor 1 antagonist prevents the proliferation and relaxation of vascular endothelial cells by sphingosine-1-phosphate. 2010 Biol. Pharm. Bull. pmid:20823564
Canals D et al. Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation: probing sphingolipid signaling at the outer plasma membrane. 2010 J. Biol. Chem. pmid:20679347
Dhami R et al. Acid sphingomyelinase deficiency attenuates bleomycin-induced lung inflammation and fibrosis in mice. 2010 Cell. Physiol. Biochem. pmid:21063112
Ratajczak MZ et al. Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex. 2010 Leukemia pmid:20357827
Alford SK et al. Prediction of sphingosine 1-phosphate-stimulated endothelial cell migration rates using biochemical measurements. 2010 Ann Biomed Eng pmid:20358290
Sun HY et al. Sphingosine-1-phosphate induces human endothelial VEGF and MMP-2 production via transcription factor ZNF580: novel insights into angiogenesis. 2010 Biochem. Biophys. Res. Commun. pmid:20382120
Liu G et al. The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. 2010 Nat. Immunol. pmid:20852647
Scherer EQ et al. Tumor necrosis factor-α enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling. 2010 Stroke pmid:20930159
Hirahara K et al. Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. 2010 Cytokine Growth Factor Rev. pmid:21084214
Kułakowska A et al. Intrathecal increase of sphingosine 1-phosphate at early stage multiple sclerosis. 2010 Neurosci. Lett. pmid:20434523
Szczepaniak WS et al. S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate. 2010 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:20435688
Muscoli C et al. Counter-regulation of opioid analgesia by glial-derived bioactive sphingolipids. 2010 J. Neurosci. pmid:21084596
Tawa H et al. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis. 2010 Circ. Res. pmid:20413783
Bolli MH et al. 2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists. 2010 J. Med. Chem. pmid:20446681
Pattanaik D and Postlethwaite AE A role for lysophosphatidic acid and sphingosine 1-phosphate in the pathogenesis of systemic sclerosis. 2010 Discov Med pmid:20807477
Ito S et al. Actin cytoskeleton regulates stretch-activated Ca2+ influx in human pulmonary microvascular endothelial cells. 2010 Am. J. Respir. Cell Mol. Biol. pmid:19648475
Alvarez SE et al. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. 2010 Nature pmid:20577214
Kamradt T and Frey O Arthritis: where are the T cells? 2010 Arthritis Res. Ther. pmid:20537200
Esche M et al. Signalling of sphingosine-1-phosphate in Müller glial cells via the S1P/EDG-family of G-protein-coupled receptors. 2010 Neurosci. Lett. pmid:20540988